Michael S. Perkinton

2.8k total citations
46 papers, 2.1k citations indexed

About

Michael S. Perkinton is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael S. Perkinton has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 25 papers in Molecular Biology and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael S. Perkinton's work include Alzheimer's disease research and treatments (26 papers), Neuroscience and Neuropharmacology Research (17 papers) and Nuclear Receptors and Signaling (7 papers). Michael S. Perkinton is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Neuroscience and Neuropharmacology Research (17 papers) and Nuclear Receptors and Signaling (7 papers). Michael S. Perkinton collaborates with scholars based in United Kingdom, United States and Ireland. Michael S. Perkinton's co-authors include Robert J. Williams, Talvinder S. Sihra, Sarah E. Hoey, Christopher C.J. Miller, Declan M. McLoughlin, Kwok‐Fai Lau, Andrew Billinton, Andrew J. Crossthwaite, James E. Ip and Graham Fraser and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Michael S. Perkinton

45 papers receiving 2.1k citations

Peers

Michael S. Perkinton
Fabien Delerue Australia
Mian Bi Australia
Steven P. Braithwaite United States
Florian Plattner United States
Arne Ittner Australia
Michael S. Perkinton
Citations per year, relative to Michael S. Perkinton Michael S. Perkinton (= 1×) peers Kengo Uemura

Countries citing papers authored by Michael S. Perkinton

Since Specialization
Citations

This map shows the geographic impact of Michael S. Perkinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Perkinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Perkinton more than expected).

Fields of papers citing papers by Michael S. Perkinton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Perkinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Perkinton. The network helps show where Michael S. Perkinton may publish in the future.

Co-authorship network of co-authors of Michael S. Perkinton

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Perkinton. A scholar is included among the top collaborators of Michael S. Perkinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Perkinton. Michael S. Perkinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chowdhury, Ekram Ahmed, Manuj Ahuja, Shufang Liu, et al.. (2023). Pharmacokinetics of AAV9 Mediated Trastuzumab Expression in Rat Brain Following Systemic and Local Administration. Journal of Pharmaceutical Sciences. 113(1). 131–140. 4 indexed citations
2.
Joshi, Lisha, et al.. (2023). cGAS-STING signalling regulates microglial chemotaxis in genome instability. Nucleic Acids Research. 52(3). 1188–1206. 16 indexed citations
3.
Hughes, Martina M., Claire Troakes, Cara L. Croft, et al.. (2023). P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes. Brain Behavior and Immunity. 114. 414–429. 10 indexed citations
4.
Chandran, Jayanth, Ekram Ahmed Chowdhury, Michael S. Perkinton, et al.. (2022). Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes. Gene Therapy. 30(1-2). 132–141. 9 indexed citations
5.
Ondrejčák, Tomáš, Igor Klyubin, Grant T. Corbett, et al.. (2018). Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble TauIn Vivo. Journal of Neuroscience. 38(50). 10595–10606. 71 indexed citations
6.
Croft, Cara L., Ksenia Kurbatskaya, Martina M. Hughes, et al.. (2017). Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death and Disease. 8(3). e2671–e2671. 41 indexed citations
7.
Ondrejčák, Tomáš, et al.. (2016). MEDI1814, a high-affinity antibody directed to the C-terminus of Aßx-42 is able to rapidly prevent or reverse synaptic plasticity impairment in the rat hippocampus in vivo. Proceedings of The Physiological Society. 1 indexed citations
8.
9.
Lau, Kwok‐Fai, Michael S. Perkinton, Lilia Rodriguez, Declan M. McLoughlin, & Christopher C.J. Miller. (2010). An X11α/FSBP complex represses transcription of the GSK3β gene promoter. Neuroreport. 21(11). 761–766. 11 indexed citations
10.
Tudor, Elizabeth L., Clare Galtrey, Michael S. Perkinton, et al.. (2010). Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 167(3). 774–785. 63 indexed citations
11.
Vos, Kurt J. De, et al.. (2010). Deficiency of the Copper Chaperone for Superoxide Dismutase Increases Amyloid-β Production. Journal of Alzheimer s Disease. 21(4). 1101–1105. 25 indexed citations
12.
Cousins, Sarah L., Sarah E. Hoey, F. Anne Stephenson, & Michael S. Perkinton. (2009). Amyloid precursor protein 695 associates with assembled NR2A‐ and NR2B‐containing NMDA receptors to result in the enhancement of their cell surface delivery. Journal of Neurochemistry. 111(6). 1501–1513. 54 indexed citations
13.
Hoey, Sarah E., Robert J. Williams, & Michael S. Perkinton. (2009). Synaptic NMDA Receptor Activation Stimulates α-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-β Production. Journal of Neuroscience. 29(14). 4442–4460. 149 indexed citations
14.
Ackerley, Steven, Andrew J. Grierson, Steven J. Banner, et al.. (2004). p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience. 26(2). 354–364. 92 indexed citations
15.
Perkinton, Michael S., Claire L. Standen, Kwok‐Fai Lau, et al.. (2004). The c-Abl Tyrosine Kinase Phosphorylates the Fe65 Adaptor Protein to Stimulate Fe65/Amyloid Precursor Protein Nuclear Signaling. Journal of Biological Chemistry. 279(21). 22084–22091. 65 indexed citations
16.
Standen, Claire L., Michael S. Perkinton, Helen L. Byers, et al.. (2003). The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2). Molecular and Cellular Neuroscience. 24(4). 851–857. 21 indexed citations
17.
Perkinton, Michael S., et al.. (2002). Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. Journal of Neurochemistry. 80(2). 239–254. 180 indexed citations
18.
Perkinton, Michael S., et al.. (2000). Expression of the glutamate transporter, EAAT4 in multiple brain regions. European Journal of Neuroscience. 12. 56–56. 1 indexed citations
19.
Perkinton, Michael S. & Talvinder S. Sihra. (1998). Presynaptic GABAB Receptor Modulation of Glutamate Exocytosis from Rat Cerebrocortical Nerve Terminals: Receptor Decoupling by Protein Kinase C. Journal of Neurochemistry. 70(4). 1513–1522. 32 indexed citations
20.
Perkinton, Michael S., et al.. (1998). Hydrogen Peroxide Enhances Signal‐Responsive Arachidonic Acid Release from Neurons: Role of Mitogen‐Activated Protein Kinase. Journal of Neurochemistry. 70(5). 2082–2090. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026